cyc 202 has been researched along with whi p180 in 2 studies
Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (whi p180) | Trials (whi p180) | Recent Studies (post-2010) (whi p180) |
---|---|---|---|---|---|
979 | 7 | 393 | 15 | 0 | 8 |
Protein | Taxonomy | cyc 202 (IC50) | whi p180 (IC50) |
---|---|---|---|
Chain A, CYCLIN-DEPENDENT KINASE 2 | Homo sapiens (human) | 1 | |
Chain A, P38 KINASE | Homo sapiens (human) | 1 | |
Proto-oncogene tyrosine-protein kinase receptor Ret | Homo sapiens (human) | 0.1922 | |
Fibroblast growth factor receptor 1 | Homo sapiens (human) | 0.125 | |
Vascular endothelial growth factor receptor 1 | Homo sapiens (human) | 0.1625 | |
Cyclin-dependent kinase 2 | Homo sapiens (human) | 1 | |
Phosphatidylinositol 3-kinase regulatory subunit alpha | Homo sapiens (human) | 0.002 | |
Ephrin type-B receptor 2 | Homo sapiens (human) | 1.2 | |
Kinesin-1 heavy chain | Homo sapiens (human) | 0.38 | |
Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.1787 | |
Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.05 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhattacharjee, AK; Ellis, W; Gerena, L; Geyer, JA; Kathcart, AK; Kyle, DE; Li, Z; Lopez-Sanchez, M; Nichols, DA; Prigge, ST; Terrell, J; Waters, NC; Woodard, CL | 1 |
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
2 other study(ies) available for cyc 202 and whi p180
Article | Year |
---|---|
Oxindole-based compounds are selective inhibitors of Plasmodium falciparum cyclin dependent protein kinases.
Topics: Amino Acid Sequence; Animals; Antimalarials; Cyclin-Dependent Kinase-Activating Kinase; Cyclin-Dependent Kinases; Enzyme Inhibitors; Humans; Indoles; Models, Molecular; Molecular Sequence Data; Plasmodium falciparum; Structure-Activity Relationship | 2003 |
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |